ZBIO 8-K 2026-10-13

Zenas BioPharma, Inc. (ZBIO) 8-K dated 2026-10-13 — accession 0001104659-26-115151. This URL is the filing, not the ZBIO hub.

Zenas BioPharma, Inc. (ZBIO) is a biotechnology company listed on US.

Zenas BioPharma, Inc. filed a 8-K on 2026-10-13. Accession 0001104659-26-115151.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.

Not investment advice. The ZBIO SEC hub lists recent forms. The stock page is the research view.